Navigation Links
Stem Cell Pioneer Recognized for 20 Years of Discovery and Innovation
Date:11/20/2012

TUCSON, Ariz., Nov. 20, 2012 /PRNewswire/ -- Dr. David Harris, Professor of Immunology at the University of Arizona and a scientific pioneer in the field of stem cell banking, was the recipient of the Arizona BioIndustry Association™ (AZBIO) 2012 award for "20 Years of Discovery and Innovation". The annual AZBIO Awards is Arizona's premier bioscience event and was held at the Phoenix Convention Center.

Dr. Harris is a graduate of Wake Forest University, the leading center for stem cell regenerative medicine and tissue engineering in the world today.

In 1991, Dr. Harris became the first person to bank stem cells for future use.  He did so by banking his first child's cord blood stem cells. In 1992, Dr. Harris founded the Arizona Cord Blood Bank which later evolved to become the Cord Blood Registry™ [CBR], the largest cord blood stem cell bank in the world. Dr. Harris continues as Chief Science Officer at CBR.

In 2011, Dr. Harris founded AdiCyte™, an adult stem cell banking company preserving adipose-derived [mesenchymal] stem cells for future use in regenerative medicine and tissue engineering. Adipose tissue, the medical name for 'fat', is the richest source of mesenchymal stem cells in the human body.

"I believe adipose stem cells have enormous potential in regenerative medicine and healing" Harris said. "My vision is to enable people to bank their stem cells for later use in treatments. Adipose stem cells can differentiate into other tissues such as heart muscle, bone, cartilage, nerve and more. Already, doctors have had success in restoring function after a heart attack, and engineering new organs such as a bladder, trachea or new blood vessels using a patient's own stem cells."

The Arizona BioIndustry Association is comprised of member organizations in business, research, government, and other professions involved in biosciences. AZBio supports the members of the Arizona bioscience community by providing access to the key resources, connections, and information that support their objectives.

AdiCyte Incorporated is the leader in biobanking of adipose tissue for use in cosmetic, surgical, reconstructive and regenerative medical treatments. Patients can now bank their adipose tissue as a biological resource for emerging treatments. The company's laboratory and processing facility is located at the University of Arizona Health Sciences Center in Tucson, Arizona. www.adicyte.com

Contact:
Stephen Grant, Corporate Communications
650.678.4999
sgrant@adicyte.com


'/>"/>
SOURCE AdiCyte
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Space Research Institute Honors Senator Hutchison with Pioneer Award
2. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
3. Air Force Office of Scientific Research hosts nanotechnology pioneer
4. Dr. Michael Yaremchuk, Leading Performer of Custom-Designed Facial Implants, Pioneers Bespoke Plastic Surgery
5. Glencoe Software and The Journal of Cell Biology Pioneer Publishing of Massive, Ultra-Resolution Images
6. Researchers pioneer worlds first HIV/AIDS nanomedicines
7. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
8. Metabolex Gout Program Recognized in Windhovers Top 10 Most Interesting Projects to Watch
9. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
10. Machine Preservation Significantly Improves Kidney Transplant Survival Over 3 Years Compared to Traditional box of ice
11. Expanded Findings for FirstMarks Completed Clinical Study for Predicting Near-Term (2-3 Years) MI
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) ...
(Date:6/27/2016)... ... , ... Parallel 6 , the leading software as a service (SaaS) ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication between ... Using the CONSULT module, patients and physicians can schedule a face to face virtual ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):